- In May 2024, Thermo Fisher Scientific expanded its portfolio of cell analysis reagents by launching a new line of automation-compatible cell permeabilization kits. These kits are optimized for high-throughput screening platforms and designed to enhance consistency and reproducibility in intracellular staining protocols. This development reflects the company’s focus on streamlining cell-based workflows and meeting the growing demand for scalable solutions in pharmaceutical and academic research
- In April 2024, BD Biosciences introduced enhanced permeabilization reagents tailored for use in multicolor flow cytometry applications. These reagents allow for more precise intracellular target detection while minimizing background noise and preserving cell integrity. The launch aims to support researchers working in immunology, oncology, and infectious disease by improving assay sensitivity and reliability
- In February 2024, Merck KGaA (MilliporeSigma) unveiled a new non-toxic, biodegradable permeabilization agent developed specifically for use in educational and low-resource laboratory settings. This innovation addresses the challenge of chemical safety while maintaining performance standards in cell-based assays, aligning with global efforts toward greener lab practices and increased reagent accessibility
- In January 2024, Agilent Technologies announced a collaboration with several academic institutions to develop a next-generation permeabilization platform integrated with real-time imaging tools. The project aims to enhance live-cell imaging applications by enabling temporary and reversible permeabilization, allowing researchers to track intracellular changes dynamically without compromising cell viability
- In December 2023, Bio-Rad Laboratories launched a custom reagent formulation service for permeabilization solutions tailored to specific research needs, including organelle-specific assays and multiplex analysis. This move highlights the increasing demand for personalized research tools and Bio-Rad's commitment to supporting advanced cell biology and translational research through customizable and scalable solutions
